Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atosiban in Repeated Implantation Failure
NCT02893722Phase 1Unknown
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Peptides, Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in Repeated Implantation Failure (RIF) comparing Atosiban Arm with Placebo Arm (2 arms). Primary endpoint: Clinical pregnancy rate at 4 weeks. Status: unknown.
02
Drugs
atosiban
03
Conditions
Repeated Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT02893722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02893722.